As of June 10, 2025, Avitar Inc (AVTI) reports a EV/EBITDA of -7.34.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Avitar Inc's EV/EBITDA to Peers
To better understand Avitar Inc's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Avitar Inc (AVTI) | -7.34 |
| Vycor Medical Inc (VYCO) | 90.04 |
| Antares Pharma Inc (ATRS) | 13.01 |
| Utah Medical Products Inc (UTMD) | 5.44 |
| OraSure Technologies Inc (OSUR) | 1.73 |
| Surgalign Holdings Inc (SRGA) | 0.22 |
Compared to its competitors, Avitar Inc's EV/EBITDA is about average compared to peers, indicating market valuation in line with industry expectations.